The Trump Administration confronts a pivotal choice on whether to adopt the Biden Administration’s misguided plan to move marijuana from Schedule I to Schedule III, with the Trump marijuana scheduling decision potentially announced at any moment and threatening decades of drug prevention progress.

Political Pressure Mounts for Dangerous Policy Change

Currently, a well-funded campaign featuring celebrity endorsements and MAGA influencers is flooding social media and Fox News, demanding the President embrace this dangerous proposal that would undermine drug prevention efforts. However, this marijuana rescheduling under Trump would represent a catastrophic departure from evidence-based substance abuse prevention policies.

Furthermore, marijuana rightfully belongs in Schedule I because raw marijuana has no accepted medical use and carries a high potential for abuse. Moreover, moving it to Schedule III would trigger widespread normalisation, directly contradicting fundamental drug and alcohol prevention principles that protect vulnerable populations.

The Scientific Case Against Rescheduling

The Biden Administration’s original proposal ignored decades of successful drug prevention research and was driven by politics rather than scientific evidence. Additionally, any Trump marijuana scheduling decision to lower marijuana’s classification would abandon proven substance abuse prevention strategies that have protected American families.

Therefore, placement in Schedule III would allow marijuana businesses to deduct advertising, marketing, and even high-THC research expenses at tax time. Consequently, this tax relief would supercharge an industry that directly opposes drug and alcohol prevention efforts whilst driving rising youth addiction, mental health crises, and emergency room visits.

Economic and Security Risks

This marijuana rescheduling under Trump would attract corporate giants and illegal operators, including those with ties to foreign governments seeking to exploit America’s legal cannabis market. Meanwhile, our communities would bear the costs in increased crime and public health expenses whilst Big Marijuana and strategic competitors profit.

Furthermore, the economic incentives created by rescheduling would strengthen illegal cartels and foreign actors already infiltrating legitimate cannabis operations. Therefore, any Trump marijuana scheduling decision must consider these national security implications alongside public health concerns.

Protecting Public Health and Safety

The stakes of this marijuana rescheduling under Trump decision extend far beyond tax policy to encompass the future of drug and alcohol prevention programmes, youth protection, and community safety. Additionally, normalising marijuana through scheduling changes would completely undermine evidence-based substance abuse prevention strategies that have proven effective for generations.

Consequently, concerned citizens must contact the President immediately to oppose this dangerous Trump marijuana scheduling decision and demand that marijuana remain in Schedule I where it belongs.

Source: Sam Action